OXCARBAZEPINSUSPENSION

European patent · EP1239832 · Deleted

Register entry

Publication number
EP1239832
Application number
EP00988803
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 19, 2000
Published
Sep 18, 2002
Granted
Jun 23, 2004
Deleted
Dec 18, 2020
Reason
Maximum term reached
IPC classes
A61K 9/10 (2006.01)
A61K 31/55 (2006.01)
Priority
GB 9930058 20.12.1999
PCT application
PCT/EP2000/012968 19.12.2000
PCT publication
WO2001/045671 28.06.2001
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 21, 2020

    Maximum term reached

    Published in Swissreg on 21.12.2020

  2. Jun 30, 2004

    Granted

    Published in +pat+ No 12 in 2004

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

SIGG, Juergen

79540 Loerrach, DE

BILLINGTON, Michael

CH-4125 Riehen

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.